According to a report published by Allied Market Research, the market size of machine learning in the pharmaceutical industry is expected to reach USD 26.2 billion by 2031. The report provides an extensive analysis of changing market dynamics, key segments, value chain, competitive scenario, and regional situation. The study provides valuable guidance to leading companies, investors, shareholders, and start-ups in developing strategies for sustainable growth and gaining a competitive edge in the market.
The global machine learning market in the pharmaceutical industry is estimated to generate $1.2 billion in 2021 and $26.2 billion by 2031, registering a CAGR of 37.9% from 2022 to 2031.
The pharmaceutical industry has seen a significant increase in the integration of machine learning (ML) technologies, driving transformative changes in drug discovery, development, and even clinical trials. ML algorithms are revolutionizing the process from identifying potential drug candidates to predicting their efficacy and safety profiles. This technology allows pharmaceutical companies to sift through vast datasets, including genomic, proteomic, and clinical data, to uncover hidden patterns and relationships and accelerate the drug discovery process.
To request a sample report: https://www.alliedmarketresearch.com/request-sample/A74504
Machine learning is a subset of artificial intelligence that uses algorithms and statistical models to enable computer systems to learn from data and make predictions and decisions without being explicitly programmed. Machine learning is a driving force in the pharmaceutical industry's pursuit of personalized medicine. Personalized medicine involves tailoring treatment to individual patients based on their unique genetic makeup, medical history, and other personal factors.
The Machine Learning in Pharmaceutical Industry market is segmented on the basis of component, company size, and deployment. and region. By component, the market is divided into solutions and services. Based on company size, the market is divided into small and medium-sized enterprises and large enterprises. Based on implementation, the market is segmented into cloud and on-premises. By region, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The market is segmented into component, company size, and deployment.
Key companies profiled in the Pharmaceutical Industry Machine Learning market report include Cyclica Inc., BioSymetrics Inc., Cloud Pharmaceuticals, Inc., Deep Genomics, Atomwise Inc., Alphabet Inc., NVIDIA Corporation, International Business Machines Corporation, Microsoft Corporation, and IBM.
The report offers a comprehensive analysis of the global ML market trends in the pharmaceutical industry by thoroughly studying various aspects of the market such as key segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards market growth. The report also highlights the current scenario and upcoming trends and developments contributing to the growth of the market. Additionally, the constraints and challenges that have the power to hinder market growth are also introduced in the report along with Porter's five forces analysis to elucidate factors such as competitive environment, bargaining power of buyers and suppliers, threat of new players, emergence of substitutes in the market.
If you have any questions, please feel free to contact our analysts. https://www.alliedmarketresearch.com/connect-to-analyst/A74504
By region, North America held the largest share in 2021, contributing almost half of the global pharmaceutical machine learning market share, and is expected to maintain its dominant share in terms of revenue in 2031. Furthermore, Asia-Pacific is expected to exhibit the fastest CAGR of 42.4% during the forecast period. The report also analyzes the European and LAMEA region markets.
Based on company size, the large enterprise segment accounted for the highest share in 2021, contributing around three-quarters of the global machine learning in pharmaceutical industry market, and is expected to maintain the lead in terms of revenue during the forecast period. Moreover, the SME segment is expected to exhibit the highest CAGR of 40.1% from 2022 to 2031.
Based on adoption, the cloud segment accounted for the highest share in 2021, accounting for more than two-thirds of the global machine learning in pharmaceutical industry market, and is expected to continue to maintain its leadership position during the forecast period. This segment is estimated to grow at the highest CAGR of 40.0% during the forecast period. This report also covers on-premises segment.
Buy now and get exclusive reports: https://www.alliedmarketresearch.com/global-machine-learning-in-pharmaceutical-industry-market/purchase-options
Covid-19 scenario:
The COVID-19 pandemic has had a positive impact on the global growth of machine learning in the pharmaceutical industry market due to the role of machine learning in drug discovery and development. Machine learning algorithms have been increasingly used in drug discovery and development in recent years, and the pandemic has accelerated this trend.
The urgent need to find treatments and vaccines for COVID-19 has led to increased investment in machine learning and artificial intelligence for drug development. Machine learning was used to quickly analyze large amounts of data related to the coronavirus and potential treatments. Virtual trials have become more common as many people are unable or unwilling to participate in traditional clinical trials due to concerns about COVID-19.
Thank you for reading this article. You can also get sections for individual chapters and report versions for regions such as North America, Europe, and Asia.
Please let us know if you have any special requests. We will provide a report upon request.
Finally, this report provides the most comprehensive market intelligence. The structure of the report is maintained to provide maximum business value. This provides key insights into market dynamics and enables strategic decision-making not only for existing market players but also for those wishing to enter the market.
contact:
david correa
1209 Orange Street,
Corporate Trust Center
wilmington, newcastle,
Delaware, USA, 19801.
International: +1-503-894-6022
Toll-free: +1-800-792-5285
UK: +44-845-528-1300
India (Pune): +91-20-66346060
Fax: +1-800-792-5285
help@alliedmarketresearch.com
About us:
Allied Market Research (AMR) is a market research and business consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR provides market research reports, business solutions, consulting services, and market insights across 11 industries. AMR employs a wide range of research methodologies to help clients make strategic business decisions and achieve sustainable growth in their market areas. We have a team of seasoned analysts and experts with extensive experience working with many Fortune 500 companies as well as small and medium-sized businesses.
Pawan Kumar, CEO of Allied Market Research, leads the organization towards delivering high quality data and insights. We have professional corporate relationships with various companies. This helps in mining market data that helps in generating accurate research data tables and confirming the highest accuracy of market predictions. All data companies in the domain are concerned. Our secondary data sourcing methodology includes detailed information included in the reports we publish, extracted through primary interviews with executives from key online and offline research, and discussions with knowledgeable industry experts and analysts.
This release was published on openPR.
